Twist Bioscience Corp
NASDAQ:TWST
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
27.95
58.88
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Twist Bioscience Corp
Wall Street
Price Targets
TWST Price Targets Summary
Twist Bioscience Corp
According to Wall Street analysts, the average 1-year price target for
TWST
is 54.25 USD
with a low forecast of 48.38 USD and a high forecast of 65.1 USD.
TWST Last Price Targets
Twist Bioscience Corp
The latest public price target was made on Sep 17, 2024 by
Catherine Schulte
from
Robert W. Baird
,
who expects
TWST
stock to
drop by 4%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Catherine Schulte
Robert W. Baird
|
46
USD
Downside 4% |
3 months ago
Sep 17, 2024
|
Baird Reiterates Outperform Rating on Twist Bioscience (TWST)
StreetInsider
|
Subbu Nambi
Guggenheim
|
53
USD
Upside 11% |
6 months ago
Jun 5, 2024
|
Twist Bioscience initiated with a Buy at Guggenheim (yesterday)
TheFly
|
|
Catherine Ramsey Schulte
Robert W. Baird
|
40
USD
Downside 17% |
7 months ago
May 3, 2024
|
Twist Bioscience price target raised to $40 from $39 at Baird
TheFly
|
Luke Sergott
Barclays
|
32
USD
Downside 33% |
1 year ago
Feb 5, 2023
|
Twist Bioscience price target lowered to $32 from $37 at Barclays
TheFly
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is TWST's stock price target?
Price Target
54.25
USD
According to Wall Street analysts, the average 1-year price target for
TWST
is 54.25 USD
with a low forecast of 48.38 USD and a high forecast of 65.1 USD.
What is Twist Bioscience Corp's Revenue forecast?
Projected CAGR
20%
For the last 7 years the
compound annual growth rate for
Twist Bioscience Corp's revenue is
62%.
The projected
CAGR
for the next 3 years is
20%.
You don't have any saved screeners yet
